| Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial (NCT02767232) | University of Colorado, Denver | 2018-07-01 |
| Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease (NCT03467620) | University of Illinois at Chicago | 2018-07-01 |
| Oral Tramadol Versus Oral Dexketoprofen for Reducing Pain During Office Hysteroscopy (NCT03585036) | Cairo University | 2018-07-01 |
| Kaffes Stent in the Management of Post-surgical Biliary Strictures (NCT03716232) | Cairo University | 2018-07-01 |
| Eight Weeks of Elbasvir/Grazoprevir in the Treatment of HCV Genotype 4 (NCT03578640) | King Fahad Medical City | 2018-07-01 |
| A Prospective Study for the Treatment of Children With Newly Diagnosed LCH Using a Cytarabine Contained Protocol (NCT04773366) | Shanghai Children's Medical Center | 2018-07-01 |
| The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI (NCT03552575) | NHS Greater Glasgow and Clyde | 2018-07-01 |
| Efficacy and Safety of Butylphthalide for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis or Endovascular Treatment (NCT03539445) | Beijing Tiantan Hospital | 2018-07-01 |
| Endothelial Cell Loss After Penetrating Keratoplasty (NCT04457063) | Alexandria University | 2018-07-01 |
| Does Gabapentin Reduce Quadriceps Muscle Weakness After Anterior Cruciate Ligament Reconstruction? (NCT03496389) | Hospital Authority, Hong Kong | 2018-07-01 |
| Eltrombopag vs. rhTPO to Increase Platelet Level After HSCT (NCT03515096) | Shenzhen Second People's Hospital | 2018-07-01 |
| Cholecalciferol on Hemodialysis Patients (NCT03602430) | Ain Shams University | 2018-07-01 |
| Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder (NCT03572933) | Marinus Pharmaceuticals | 2018-06-30 |
| Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute Pharyngitis (NCT03583658) | Sanofi | 2018-06-30 |
| A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer (NCT03709316) | Zai Lab (Shanghai) Co., Ltd. | 2018-06-30 |
| An Evaluation of the Efficacy of HEXI-PREP by Clinell Wipes (NCT03417661) | Gama Healthcare Ltd. | 2018-06-29 |
| DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness (NCT04219982) | Repurposed Therapeutics, Inc. | 2018-06-29 |
| QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery (NCT03510897) | Quark Pharmaceuticals | 2018-06-29 |
| DYmista NAsal Spray in CHInese Patients (NCT03599791) | MEDA Pharma GmbH & Co. KG | 2018-06-29 |
| Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) (NCT03546842) | Merck Sharp & Dohme LLC | 2018-06-29 |
| Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis (NCT03575871) | Pfizer | 2018-06-29 |
| Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789) (NCT03515837) | Merck Sharp & Dohme LLC | 2018-06-29 |
| Study of Remimazolam Tosilate in Patients Undergoing Colonoscopy (NCT03779061) | Jiangsu HengRui Medicine Co., Ltd. | 2018-06-28 |
| Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer (NCT03556358) | Tanvex BioPharma USA, Inc. | 2018-06-28 |
| Compare Neoadjuvant Chemotherapy of DOS Versus SOX in Locally Advanced Gastric Adenocarcinoma. (NCT03691454) | Peking University | 2018-06-28 |
| Balloon-occluded Retrograde Transvenous Obliteration for Gastric Variceal Rebleeding (NCT06106971) | Kaohsiung Veterans General Hospital. | 2018-06-28 |
| Triple Therapy With Tegoprazan in H. Pylori Positive Patients (NCT03498456) | HK inno.N Corporation | 2018-06-28 |
| Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis (NCT03565887) | RVL Pharmaceuticals, Inc. | 2018-06-28 |
| Randomised Open Label Trial of Hypertonic Saline and Carbocisteine in Bronchiectasis (CLEAR) (NCT04140214) | Belfast Health and Social Care Trust | 2018-06-27 |
| HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients (NCT03569891) | CSL Behring | 2018-06-27 |
| A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis (NCT03559270) | Eli Lilly and Company | 2018-06-27 |
| A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and Children (NCT05099029) | Enimmune Corporation | 2018-06-27 |
| Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers. (NCT03370874) | Anterogen Co., Ltd. | 2018-06-27 |
| A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) (NCT03474107) | Astellas Pharma Global Development, Inc. | 2018-06-27 |
| PeriOperative ISchemic Evaluation-3 Trial (NCT03505723) | Population Health Research Institute | 2018-06-27 |
| A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease (NCT03464097) | Celgene | 2018-06-27 |
| A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) (NCT03535194) | Eli Lilly and Company | 2018-06-26 |
| Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance (NCT03597516) | Ritter Pharmaceuticals, Inc. | 2018-06-26 |
| A Study Evaluating the Efficacy and Safety of AG-348 in Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD) (NCT03559699) | Agios Pharmaceuticals, Inc. | 2018-06-26 |
| Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis (NCT03504852) | Novartis Pharmaceuticals | 2018-06-25 |
| PRO 140 in Treatment-Experienced HIV-1 Subjects (NCT03902522) | CytoDyn, Inc. | 2018-06-25 |
| A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation (NCT03535415) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2018-06-25 |
| Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years. (NCT05037435) | Limited Liability Company Pharm Aid | 2018-06-25 |
| A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs (NCT03459534) | Il-Yang Pharm. Co., Ltd. | 2018-06-25 |
| A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children (NCT03574389) | Pfizer | 2018-06-23 |
| Maintenance Treatment of Renal Anemia in Dialysis Subjects (NCT03543657) | Bayer | 2018-06-23 |
| Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department (NCT03571737) | East Carolina University | 2018-06-23 |
| Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C (NCT03633279) | Dayanand Medical College and Hospital | 2018-06-22 |
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH) (NCT03480763) | Merck Sharp & Dohme LLC | 2018-06-22 |
| Sensorial and Physiological Mechanism-based Assessments of Perioperative Pain (NCT03537612) | Dr. Jean A. Ouellet, MD, FRCSC | 2018-06-22 |
| Prostate Cancer Patient Management With 18F-DCFPyL PET/CT (NCT03459820) | Sir Mortimer B. Davis - Jewish General Hospital | 2018-06-22 |
| Zone 2 Flexor Tendon Repair With CoNextions TR Implant System (NCT03622372) | CoNextions Medical | 2018-06-21 |
| A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer. (NCT03504397) | Astellas Pharma Global Development, Inc. | 2018-06-21 |
| Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS (NCT03505021) | Orion Corporation, Orion Pharma | 2018-06-21 |
| Pecto-Intercostal Fascial Block for Postoperative Analgesia After Cardiac Surgery (NCT03482973) | Beth Israel Deaconess Medical Center | 2018-06-21 |
| Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion) (NCT03560466) | Sanofi | 2018-06-21 |
| Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease (NCT03425539) | Idorsia Pharmaceuticals Ltd. | 2018-06-21 |
| DENdritic Cell Immunotherapy for Mesothelioma (NCT03610360) | Amphera BV | 2018-06-21 |
| A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea (NCT03564119) | Sol-Gel Technologies, Ltd. | 2018-06-21 |
| An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma (NCT04607629) | AO GENERIUM | 2018-06-20 |
| Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD (NCT03745261) | Henan University of Traditional Chinese Medicine | 2018-06-20 |
| A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) (NCT03573908) | Ironwood Pharmaceuticals, Inc. | 2018-06-20 |
| Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) (NCT03608397) | Revance Therapeutics, Inc. | 2018-06-20 |
| Study of Safety of RVL-1201 in Treatment of Blepharoptosis (NCT03536949) | RVL Pharmaceuticals, Inc. | 2018-06-20 |
| A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) (NCT03561090) | Ironwood Pharmaceuticals, Inc. | 2018-06-20 |
| Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma (NCT03582293) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2018-06-19 |
| Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6). (NCT03526861) | LEO Pharma | 2018-06-19 |
| A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali (NCT02927496) | The Task Force for Global Health | 2018-06-19 |
| A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer (NCT03574571) | Memorial Sloan Kettering Cancer Center | 2018-06-19 |
| Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India) (NCT03529123) | Sanofi | 2018-06-19 |
| Niemann-Pick Type C Treatment With Adrabetadex for Symptoms of Brain and Nervous System (NCT03643562) | Mandos LLC | 2018-06-18 |
| An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) (NCT03518086) | Eli Lilly and Company | 2018-06-18 |
| A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety (NCT03541174) | Idorsia Pharmaceuticals Ltd. | 2018-06-18 |
| A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea (NCT03448939) | Sol-Gel Technologies, Ltd. | 2018-06-18 |
| Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). (NCT03464019) | Milestone Pharmaceuticals Inc. | 2018-06-18 |
| Study of Rapastinel as Monotherapy in Patients With MDD (NCT03560518) | Naurex, Inc, an affiliate of Allergan plc | 2018-06-15 |
| Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients (NCT03278717) | University College, London | 2018-06-15 |
| Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT (NCT03530085) | Nanfang Hospital, Southern Medical University | 2018-06-15 |
| A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) (NCT03525444) | Vertex Pharmaceuticals Incorporated | 2018-06-15 |
| Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) (NCT03521934) | Lexicon Pharmaceuticals | 2018-06-15 |
| Neuroprotectant for Hypertensive Intracerebral Hemorrhage (NCT03546283) | Rong Hu, MD | 2018-06-15 |
| A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features (NCT03573297) | AbbVie | 2018-06-15 |
| Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study) (NCT03570281) | Samsung Medical Center | 2018-06-15 |
| Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease (NCT03856853) | Beijing Continent Pharmaceutical Co, Ltd. | 2018-06-15 |
| Clinical Trial to Evaluate the Tolerability and Efficacy of Microencapsulated Calcium Carbonate (NCT03452696) | Instituto Palacios | 2018-06-15 |
| Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex (NCT03453632) | University Hospital, Toulouse | 2018-06-14 |
| A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer (NCT03493854) | Hoffmann-La Roche | 2018-06-14 |
| Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT03500549) | Apellis Pharmaceuticals, Inc. | 2018-06-14 |
| Nebulized Morphine in Chest Trauma Patients: A Prospective Study (NCT03580187) | University Hospital, Mahdia | 2018-06-14 |
| The Effects of Iontophoresis in Women With Gynoid Hidrolipodystrophy. (NCT03556917) | Universidade Norte do Paraná | 2018-06-14 |
| An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). (NCT03583372) | Urovant Sciences GmbH | 2018-06-14 |
| China Antihypertensive Trial in Acute Ischemic Stroke II (NCT03479554) | Tulane University | 2018-06-13 |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT03536884) | UCB Biopharma SRL | 2018-06-13 |
| Tamoxifen in Duchenne Muscular Dystrophy (NCT03354039) | University Hospital, Basel, Switzerland | 2018-06-12 |
| Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoctocog Alfa in Patients With Haemophilia A Following Inhibitor Development in NN7170-4213 Trial (NCT03588741) | Novo Nordisk A/S | 2018-06-12 |
| Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study (NCT03563053) | Quince Therapeutics S.p.A. | 2018-06-12 |
| A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in Infants (NCT03822767) | Sinovac Biotech Co., Ltd | 2018-06-12 |
| Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX) (NCT03614663) | Zynerba Pharmaceuticals, Inc. | 2018-06-12 |
| CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy (NCT03529279) | Sun Yat-sen University | 2018-06-12 |
| PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders (NCT04353986) | Ain Shams University | 2018-06-11 |